Literature DB >> 26970107

Empirical extensions of the lasso penalty to reduce the false discovery rate in high-dimensional Cox regression models.

Nils Ternès1,2, Federico Rotolo1,2, Stefan Michiels1,2.   

Abstract

Correct selection of prognostic biomarkers among multiple candidates is becoming increasingly challenging as the dimensionality of biological data becomes higher. Therefore, minimizing the false discovery rate (FDR) is of primary importance, while a low false negative rate (FNR) is a complementary measure. The lasso is a popular selection method in Cox regression, but its results depend heavily on the penalty parameter λ. Usually, λ is chosen using maximum cross-validated log-likelihood (max-cvl). However, this method has often a very high FDR. We review methods for a more conservative choice of λ. We propose an empirical extension of the cvl by adding a penalization term, which trades off between the goodness-of-fit and the parsimony of the model, leading to the selection of fewer biomarkers and, as we show, to the reduction of the FDR without large increase in FNR. We conducted a simulation study considering null and moderately sparse alternative scenarios and compared our approach with the standard lasso and 10 other competitors: Akaike information criterion (AIC), corrected AIC, Bayesian information criterion (BIC), extended BIC, Hannan and Quinn information criterion (HQIC), risk information criterion (RIC), one-standard-error rule, adaptive lasso, stability selection, and percentile lasso. Our extension achieved the best compromise across all the scenarios between a reduction of the FDR and a limited raise of the FNR, followed by the AIC, the RIC, and the adaptive lasso, which performed well in some settings. We illustrate the methods using gene expression data of 523 breast cancer patients. In conclusion, we propose to apply our extension to the lasso whenever a stringent FDR with a limited FNR is targeted.
Copyright © 2016 John Wiley & Sons, Ltd. Copyright © 2016 John Wiley & Sons, Ltd.

Entities:  

Keywords:  Cox model; false discovery rate; lasso penalty; prognostic biomarkers; variable selection

Mesh:

Substances:

Year:  2016        PMID: 26970107     DOI: 10.1002/sim.6927

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  31 in total

1.  Accommodating missingness in environmental measurements in gene-environment interaction analysis.

Authors:  Mengyun Wu; Yangguang Zang; Sanguo Zhang; Jian Huang; Shuangge Ma
Journal:  Genet Epidemiol       Date:  2017-06-28       Impact factor: 2.135

2.  Risk Factor Identification in Heterogeneous Disease Progression with L1-Regularized Multi-state Models.

Authors:  Xuan Dang; Shuai Huang; Xiaoning Qian
Journal:  J Healthc Inform Res       Date:  2021-01-04

Review 3.  Statistical controversies in clinical research: prognostic gene signatures are not (yet) useful in clinical practice.

Authors:  S Michiels; N Ternès; F Rotolo
Journal:  Ann Oncol       Date:  2016-09-15       Impact factor: 32.976

4.  Identification of biomarker-by-treatment interactions in randomized clinical trials with survival outcomes and high-dimensional spaces.

Authors:  Nils Ternès; Federico Rotolo; Georg Heinze; Stefan Michiels
Journal:  Biom J       Date:  2016-11-15       Impact factor: 2.207

5.  Robust estimation of the expected survival probabilities from high-dimensional Cox models with biomarker-by-treatment interactions in randomized clinical trials.

Authors:  Nils Ternès; Federico Rotolo; Stefan Michiels
Journal:  BMC Med Res Methodol       Date:  2017-05-22       Impact factor: 4.615

6.  Noninvasive scoring system for significant inflammation related to chronic hepatitis B.

Authors:  Mei-Zhu Hong; Linglong Ye; Li-Xin Jin; Yan-Dan Ren; Xiao-Fang Yu; Xiao-Bin Liu; Ru-Mian Zhang; Kuangnan Fang; Jin-Shui Pan
Journal:  Sci Rep       Date:  2017-03-10       Impact factor: 4.379

7.  Genome-wide copy number analyses of samples from LACE-Bio project identify novel prognostic and predictive markers in early stage non-small cell lung cancer.

Authors:  Federico Rotolo; Chang-Qi Zhu; Elisabeth Brambilla; Stephen L Graziano; Ken Olaussen; Thierry Le-Chevalier; Jean-Pierre Pignon; Robert Kratzke; Jean-Charles Soria; Frances A Shepherd; Lesley Seymour; Stefan Michiels; Ming-Sound Tsao
Journal:  Transl Lung Cancer Res       Date:  2018-06

8.  Incidence Trends and Risk Prediction Nomogram for Suicidal Attempts in Patients With Major Depressive Disorder.

Authors:  Sixiang Liang; Jinhe Zhang; Qian Zhao; Amanda Wilson; Juan Huang; Yuan Liu; Xiaoning Shi; Sha Sha; Yuanyuan Wang; Ling Zhang
Journal:  Front Psychiatry       Date:  2021-06-23       Impact factor: 4.157

9.  Identification and validation of a robust autophagy-related molecular model for predicting the prognosis of breast cancer patients.

Authors:  Jian-Ying Ma; Qin Liu; Gang Liu; Shasha Peng; Gaosong Wu
Journal:  Aging (Albany NY)       Date:  2021-06-29       Impact factor: 5.682

10.  A novel messenger RNA signature as a prognostic biomarker for predicting relapse in pancreatic ductal adenocarcinoma.

Authors:  Guodong Shi; Jingjing Zhang; Zipeng Lu; Dongfang Liu; Yang Wu; Pengfei Wu; Jie Yin; Hao Yuan; Qicong Zhu; Lei Chen; Yue Fu; Yunpeng Peng; Yan Wang; Kuirong Jiang; Yi Miao
Journal:  Oncotarget       Date:  2017-12-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.